Find a Trial

Trial Summary


Protocol No.PHO-PFIZER-PRADHAN-ADVL1921
StatusSUSPENDED
Principal InvestigatorFerguson, Michael
ScopeNational
PhasePhase I
Age GroupAdults and Children
TitlePHASE 1 STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR FRACTORY SOLID TUMORS
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactFernanda C. Rankin, Phone:
    Pager:
    Email: fecarnev@iu.edu